This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Hovione Scientia Limited. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Joana Fernandes: Innovator in Pharmaceutical Formulations
Introduction
Joana Fernandes is a prominent inventor based in Lançada, Portugal. She has made significant contributions to the field of pharmaceutical formulations, particularly in the treatment of respiratory diseases. With a total of two patents to her name, her work focuses on innovative solutions for asthma and chronic obstructive pulmonary disease.
Latest Patents
Joana's latest patents include an amorphous form of vilanterol trifenatate and processes for its preparation. This invention relates to a unique amorphous form of vilanterol trifenatate, characterized by its X-ray powder diffraction (XRPD) pattern. It is designed for use in pharmaceutical formulations aimed at treating respiratory diseases. Additionally, she has developed new crystalline forms of vilanterol trifenatate, which also focus on the treatment of respiratory conditions. These crystalline forms are defined by specific XRPD patterns, showcasing her innovative approach to pharmaceutical development.
Career Highlights
Joana Fernandes works at Hovione Scientia Limited, where she continues to advance her research and development efforts. Her work has been instrumental in creating effective treatments for respiratory diseases, showcasing her dedication to improving patient outcomes.
Collaborations
Joana collaborates with notable colleagues, including Nuno Torres Lourenço and Luis Sobral. Their combined expertise contributes to the innovative projects at Hovione Scientia Limited.
Conclusion
Joana Fernandes stands out as a key inventor in the pharmaceutical industry, with her patents reflecting her commitment to addressing critical health challenges. Her contributions are paving the way for advancements in the treatment of respiratory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile